Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

X4 Pharmaceuticals (XFOR) Long-Term Debt Issuances (2018 - 2023)

X4 Pharmaceuticals' Long-Term Debt Issuances history spans 4 years, with the latest figure at $22.5 million for Q3 2023.

  • For Q3 2023, Long-Term Debt Issuances changed N/A year-over-year to $22.5 million; the TTM value through Dec 2024 reached $22.5 million, changed 0.0%, while the annual FY2024 figure was $20.0 million, 11.11% down from the prior year.
  • Long-Term Debt Issuances reached $22.5 million in Q3 2023 per XFOR's latest filing, up from $7.5 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $22.5 million in Q3 2023 to a low of $4.9 million in Q1 2020.
  • Average Long-Term Debt Issuances over 3 years is $11.2 million, with a median of $8.7 million recorded in 2019.